Stereotaxis Inc(NASDAQ:STXS) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during After-hours on Aug 9, 2016. Earnings per share were $-0.11.
Stereotaxis Inc (STXS) shares turned negative on Wednesdays trading session with the shares closing down -0.039 points or -5.42% at a volume of 68,554. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $0.72. The peak price level was also seen at $0.72 while the days lowest was $0.6775. Finally the shares closed at $0.681. The 52-week high of the shares is $2.53 while the 52-week low is $0.5402. According to the latest information available, the market cap of the company is $15 M.
Several Insider Transactions has been reported to the SEC. On Jun 16, 2015, Fred A Middleton (director) sold 26,064 shares at $1.57 per share price.Also, On Mar 17, 2015, David Benfer (director) purchased 3,000 shares at $1.95 per share price.On Mar 6, 2015, Robert J Messey (director) sold 1,410 shares at $2.33 per share price, according to the Form-4 filing with the securities and exchange commission.
Stereotaxis Inc. (Stereotaxis) designs manufactures and markets robotic systems and instruments for use primarily by electrophysiologists for the treatment of abnormal heart rhythms known as cardiac arrhythmias. The Company offers its Epoch Solution a remote robotic navigation system for use in a hospital’s interventional surgical suite or interventional lab. The Epoch Solution consists of the Niobe ES Robotic Magnetic Navigation System (Niobe ES system) Odyssey Information Management Solution (Odyssey Solution) and the Vdrive Robotic Navigation System (Vdrive system). The components of the Niobe system include Niobe Remote Magnetic Navigation System and Cardiodrive Automated Catheter Advancement System. The Odyssey Solution offers a real-time information solution to manage control record and share procedures across networks or around the world. The Vdrive system provides navigation and stability for diagnostic and ablation devices.